Trial intelligence / Profile preview

INFLUENCE Trial: Optimizing fludarabine exposure during lymphodepletion for CAR T cell therapy in B-ALL

2025-523096-34-00Phase 3Authorised

Sponsor

Princess Máxima Center for Pediatric Oncology

Start

Apr 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

5